This information was published on 2025-06-19T00:01:14 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2514776 |
| (220) |
18 Jan 2025
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of autoimmune, gastrointestinal, and inflammatory diseases and disorders, pharmaceutical preparations for the treatment of skin disorders, pharmaceutical preparations for the treatment of hair loss disorders, pharmaceutical preparations, namely, medicated dermatological preparations, pharmaceutical preparations for the treatment of alopecia areata, atopic dermatitis, vitiligo, irritable bowel disease, ulcerative colitis, Crohn's disease and rheumatoid arthritis. |
| (540) | LEQSELVI |
| (550) | Word |
| (730) |
Sun Pharmaceutical Industries, Inc.
|
| (750) |
Sun Pharma ANZ PTY LTD
|
Find out more about publications on the About page.